VeriMomsymphytum officinale root extract est-il sûr pendant la grossesse ?
Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
Pregnancy-safe products containing symphytum officinale root extract
Alternatives sûres à symphytum officinale root extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- symphytum officinale root extract est-il sûr pendant la grossesse ?
- Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
- symphytum officinale root extract est-il sûr pendant l'allaitement ?
- Because PAs in comfrey are hepatotoxic and have been implicated in infant toxicity and are discouraged during lactation, breastfeeding is cautioned; dermal/topical exposure can result in measurable but low absorption and there are case reports and regulatory warnings advising avoidance with nursing due to risk to the suckling infant. Mechanism is PA metabolic activation with genotoxic/hepatotoxic effects. (Sources: EMA monograph; regulatory advisories; PubMed reviews).
- symphytum officinale root extract est-il sûr pour la peau de bébé ?
- Infants (0–3 yr) have higher skin permeability and higher surface‑area‑to‑weight, so exposure score is increased. Given comfrey’s content of pyrrolizidine alkaloids (hepatotoxic/genotoxic), and documented infant/fetal cases and regulatory cautions (including advice to avoid use on nursing mothers and infants), residual PA on skin or transfer via breast/chest application could pose risk; although dermal PA absorption was shown to be low in one ex vivo study, infant susceptibility and cases justify conservative approach. (Sources: PubMed review; skin permeation study; regulatory guidance).
- Comment VeriMom évalue-t-il symphytum officinale root extract ?
- VeriMom évalue symphytum officinale root extract à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à symphytum officinale root extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à symphytum officinale root extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.